CAPTRUST Financial Advisors
LUCD icon

CAPTRUST Financial Advisors’s Lucid Diagnostics LUCD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,421
Closed -$3K – 3194
2022
Q2 		$3K Buy
+1,421
New +$3.16K ﹤0.01% 4310

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CAPTRUST Financial Advisors's LUCD Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Lucid Diagnostics (LUCD) in Q3 2022, closing a stake of 1,421 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in LUCD in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 23 funds tracked by Wall St. Rank hold LUCD as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Lucid Diagnostics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,421 Lucid Diagnostics shares in Q3 2022, an estimated $3K.
  • CAPTRUST Financial Advisors first reported a position in Lucid Diagnostics in Q2 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Lucid Diagnostics position peaked at $3K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.